“Peter Rheinstein”的意思、由来-开放百科全书

Peter Howard Rheinstein (born September 7, 1943) is an American physician, lawyer, author, and administrator (both private and governmental). He was an official of the Food and Drug Administration (FDA) 1974-1999.

Education

Rheinstein received a B.A. with high honors from Michigan State University in 1963, an M.S. in mathematics from Michigan State University in 1964, an M.D. from Johns Hopkins University in 1967, and a J.D. from the University of Maryland School of Law in 1973. At Michigan State University Rheinstein was noted for his facility in mathematics.^[2]

Food and Drug Administration

Rheinstein was director of the Drug Advertising and Labeling Division, Food and Drug Administration, Rockville, 1974-1982;^[3] he was acting deputy director Office of Drugs, 1982–83, acting director Office of Drugs; 1983–84, director Office of Drug Standards, 1984–90,^[4]^[5] director medicine staff Office Health Affairs, 1990-99.^[6]^[7] While at FDA Rheinstein developed precedents for Food and Drug Administration regulation of prescription drug promotion, initiated FDA’s first patient medication information program; implemented the Drug Price Competition and Patent Term Restoration Act of 1984, and authored medication goals for Healthy People 2000 and 2010.^[8]^[9]^[10]^[11]^[12]^[13] Judy Woodruff interviewed Rheinstein about generic drug safety on the McNeil-Lehrer NewsHour.^[14]

Later career

From 1999 – 2004, Rheinstein was senior vice president for medical and clinical affairs, Cell Works, Inc., Baltimore. Among other projects, Cell Works wanted to develop a blood test for anthrax, similar to a system for cancer cells it produced. "It's something that companies like ours can incorporate into our diagnostic technology," Rheinstein told the Washington Times. Biodefense projects "create new technologies, the spin-offs of which can be commercialized into some pretty good things." ^[15] In 2000 Rheinstein became president of Severn Health Solutions in Severna Park, Maryland. In 2010 Rheinstein was named president of the Academy of Physicians in Clinical Research ^[16] and in 2011 was named chairman of the American Board of Legal Medicine. Rheinstein was named chairman of the United States Adopted Names Council in 2012. Rheinstein is a member of Phi Kappa Phi,^[17] and vice-president of the Intercultural Friends Foundation.^[18] Rheinstein is publisher of Discovery Medicine and chairman of MedData Foundation.^[19] He is president-elect of the Academy of Medicine of Washington, DC.^[20]

Publications

External links

References

1. ^American College of Legal Medicine Gold Medal, recipients {{webarchive|url=https://web.archive.org/web/20130818014554/http://aclm.org/dirAbout/Gold-Medal-Recipients.aspx |date=2013-08-18 }}
2. ^Steven G. Krantz. Mathematical Apocrypha: Stories and Anecdotes of Mathematicians and the Mathematical. The Mathematical Association of America (July 15, 2002) pp187-188
3. ^VICTOR COHN. FALSE ADS CHARGED U. S. Impounds Millions of Birth Control Pills. Los Angeles Times. Jan 1, 1975, p A1
4. ^SURGEONS' MARKERS CITED FOR INFECTIONS. Philadelphia Inquirer. July 23, 1987
5. ^[https://www.nytimes.com/1990/08/04/style/consumer-s-world-diet-pill-death-raises-questions-on-fda-role.html BARRY MEIER. Diet-Pill Death Raises Questions On F.D.A. Role. New York Times August 4, 1990]
6. ^WILL PEOPLE COUGH UP $50 FOR $5 DRUG? ORGANIDIN'S MAKERS REPLACED AN INGREDIENT WITH ONE THAT'S AVAILABLE OVER THE COUNTER. THEY KEPT THE PRICE. Philadelphia Inquirer. Oct 14, 1994 A2.
7. ^Hospitals' Fatal Mistakes Repeated Elsewhere. Beaver County Times. Oct 24, 1993
8. ^Peter Rheinstein. The Wrong Way to Control Drug Prices. Washington Times April 19, 2016
9. ^Dylan Scott. The untold story of TV's first prescription drug ad. THE WEEK December 28, 2015
10. ^Lazar EJ, Banks D, Graham C, Adams D, Rheinstein PH, Gross M, Witt AM.Drug company sponsorship of education: the response to the FDA draft concept paper. JAMA. 1992 Jul 1;268(1):53-4 {{PMID|1608109}}
11. ^Peck CC, Rheinstein PH. FDA regulation of prescription drug advertising. JAMA. 1990 Nov 14;264(18):2424-5 {{PMID|2232001}}
12. ^Rheinstein PH. Regulatory status of pancreatic enzyme preparations. JAMA. 1990 May 9;263(18):2491-2 {{PMID|2329638}}
13. ^Faich GA, Morrison J, Dutra EV Jr, Hare DB, Rheinstein PH. Reassurance about generic drugs. N Engl J Med. 1987 Jun 4;316(23):1473-5 {{PMID|3574426}}
14. ^[https://www.youtube.com/watch?v=sjUmhKvyjw4 Judy Woodruff interviews Peter Rheinstein about generic drug safety on the McNeil-Lehrer NewsHour].
15. ^Tom Ramstack. Germ research gets urgent; Bioterrorism fuels interest, funding of scientific projects. Washington Times. June 9, 2003 page 1.
16. ^Academy of Physicians in Clinical Research - AMA Delegate's Report 2013
17. ^[https://lawyers.justia.com/lawyer/peter-rheinstein-616187 Peter Rheinstein - Lawyer - Justia]
18. ^[https://archive.today/20130411073914/http://biography.marquiswhoswho.com/healthcare-executive/peter-rheinstein/3989512 Peter Rheinstein's Biography from Who's Who in America (April 2013)]
19. ^MedData Foundation official website
20. ^[https://www.acadmeddc.org/leadership/ Academy of Medicine of Washington, DC leadership]
21. ^[https://www.apcrnet.org/sites/default/files/APCR%20Spring%202017_FINAL.pdf Peter Rheinstein's recent AMA House of Delegate Articles (pages 7 and 8, May 2017)]
22. ^[https://www.apcrnet.org/sites/default/files/APCR%20Delegate%27s%20Report%20I-15.pdf Peter Rheinstein's recent AMA House of Delegate Articles, November 2015]
23. ^[https://www.apcrnet.org/sites/default/files/APCR%20Delegate%27s%20Report%20A-15.pdf Peter Rheinstein's recent AMA House of Delegate Articles, June 2015]